PIN-PHO1201: Multicenter, open-label, randomized, controlled phase III clinical study of the efficacy and safety of photodynamic therapy using porfimer sodium for injection as treatment for unresectable advanced perihilar cholangiocarcinoma

July 21, 2015
Gastroenterology - Stomach
Principal Investigator: Cyrus R Piraka, MD

The purpose of this study is to examine the effect, good or bad, of photodynamic therapy (PDT) using porfimer sodium when combined with the standard commonly-used drugs (Gemcitabine/cisplatin) on you and your type of bile duct cancer to find out which is better.

Please contact us for a full list of criteria.

  • New diagnosis of perihilar cholangiocarcinoma for which surgery is not an option
  • Have not yet started chemotherapy and be willing to have your chemotherapy at a Henry Ford facility
Joanne Dupuis, R.N.
(313) 916-1962